Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting
Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024
Azitra Announces Full Year 2023 Financial Results and Provides Business Updates
Azitra, Inc. Announces Closing of Public Offering
Azitra, Inc. Announces Pricing of Public Offering
Azitra, Inc. Strengthens Intellectual Property Portfolio
Azitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024
Azitra, Inc. Announces Third Quarter 2023 Financial Results and Business Updates
BRANFORD, Conn., Aug. 29, 2023 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, announced today that Travis Whitfill, COO, will present an overview of the Company at the H.C. Wainwright 25th Annual Global Investment Conference, being held from September 11-13, 2023. Company management will also be participating in one-on-one meetings during the conference.
BRANFORD, Conn., July 19, 2023 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced the addition of two members to its board of directors, Barbara Ryan and John Schroer.